Berthe M P Aleman

12PUBLICATIONS
65CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesEpidemiological methodsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 13, 2025
Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects.

Shahin Roshani, Flora E van Leeuwen, Sara Rossetti

|Jun 05, 2025
Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristics.

Eline M J Lammers, Berthe M P Aleman, Michael Schaapveld

|Apr 18, 2024
Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.

Eline M J Lammers, Josée M Zijlstra, Valesca P Retèl

|Feb 15, 2024
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.

Suzanne I M Neppelenbroek, Yvonne M Geurts, Berthe M P Aleman

|Nov 15, 2023
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.

Massimo Federico, Catherine Fortpied, Yana Stepanishyna

|Apr 11, 2023
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.

Sidsel J Juul, Sára Rossetti, Michal Kicinski

Pageof 2

Frequent Collaborators

6 joint publications

Flora E van Leeuwen

5 joint publications

Michael Schaapveld

4 joint publications

Josée M Zijlstra

4 joint publications

Pieternella J Lugtenburg